UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-A

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR 12(g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

 

NILE THERAPEUTICS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   88-0363465

(State of incorporation

or organization)

  

(I.R.S. Employer

Identification No.)

 

115 Sansome Street, Suite #310

San Francisco, California

   94104
(Address of principal executive offices)   (Zip code)

 

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class

to be so registered

  

Name of each exchange on which

each class is to be registered

Common Stock, par value $0.001 per share   The NASDAQ Stock Market LLC

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box.    x   If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box.    ¨

Securities Act registration statement file number to which this form relates:    333-146843

Securities to be registered pursuant to Section 12(g) of the Act:    Not Applicable

 

 

 

Item 1. Description of Registrant’s Securities to be Registered.

The description of the Common Stock of Nile Therapeutics, Inc. (the “Registrant”) set forth under the caption “Description of Securities” in the Registrant’s Registration Statement on Form SB-2 (File No. 333-146843) as originally filed with the Securities and Exchange Commission on October 22, 2007, and as subsequently amended on November 2, 2007 (the “Registration Statement”), and in the prospectus included in the Registration Statement, is hereby incorporated by reference in response to this item.

 

Item 2. Exhibits.

Because no other securities of the Registrant are registered on The NASDAQ Stock Market LLC, and the securities being registered by this Form 8-A are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, no exhibits are required to be filed with this Form 8-A.

SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

Date:    May 9, 2008     NILE THERAPEUTICS, INC.
      By:   /s/    Peter M. Strumph        
      Name:   Peter M. Strumph
      Title:   Chief Executive Officer